Peggy S Lai1, William J Sheehan2, Jonathan M Gaffin2, Carter R Petty3, Brent A Coull4, Diane R Gold5, Wanda Phipatanakul6. 1. Division of Pulmonary and Critical Care, Massachusetts General Hospital, Boston, MA; Harvard Medical School, Boston, MA. 2. Harvard Medical School, Boston, MA; Boston Children's Hospital, Brigham and Women's Hospital, Boston, MA. 3. Boston Children's Hospital, Brigham and Women's Hospital, Boston, MA. 4. Department of Environmental Health, Harvard School of Public Health, Boston, MA; Department of Biostatistics, Harvard School of Public Health, Boston, MA. 5. Harvard Medical School, Boston, MA; Boston Children's Hospital, Brigham and Women's Hospital, Boston, MA; Channing Laboratory, Brigham and Women's Hospital, Boston, MA. 6. Harvard Medical School, Boston, MA; Boston Children's Hospital, Brigham and Women's Hospital, Boston, MA. Electronic address: wanda.phipatanakul@childrens.harvard.edu.
Abstract
BACKGROUND: Endotoxin exposure is associated with airway inflammation. Children spend 6 to 8 h/d in school, yet the effect of school-specific endotoxin exposure on asthma morbidity is not well understood. METHODS: In this longitudinal cohort study, 248 students with asthma, from 38 inner-city schools, underwent baseline phenotyping and follow-up. Clinical outcomes were evaluated throughout the academic school year and linked to classroom-specific dust and air endotoxin levels as well as home dust endotoxin levels. The primary outcome was maximum asthma symptom-days per 2-week period. RESULTS: Classrooms had higher settled dust endotoxin levels compared with homes (14.3 endotoxin unit/mg vs 11.3 endotoxin unit/mg; P = .02). Airborne endotoxin levels exceeding recommended occupational exposure limits for adults were recorded in 22.0% of classrooms. Classroom air endotoxin levels were independently associated with increased maximum symptom-days in children with nonatopic asthma, but not in those with atopic asthma (interaction P = .03). Adjusting for home exposures, classroom endotoxin exposure was independently associated with a dose-dependent increase in asthma symptom-days for children with nonatopic asthma (adjusted incidence rate ratio, 1.16 [95% CI, 1.03-1.31]; P = .02). In these subjects, maximum symptom-days increased by 1.3 days for each 14-day period when comparing students in classrooms with the lowest endotoxin levels compared with average measured levels. CONCLUSIONS: Inner-city children with asthma are exposed to high levels of airborne endotoxin at school, resulting in increased asthma symptoms in children with nonatopic asthma. Mitigation of school-related exposures may represent a strategy to decrease asthma morbidity in this population. TRIAL REGISTRY: ClinicalTrials.gov; No.: NCT01756391; URL: www.clinicaltrials.gov.
BACKGROUND: Endotoxin exposure is associated with airway inflammation. Children spend 6 to 8 h/d in school, yet the effect of school-specific endotoxin exposure on asthma morbidity is not well understood. METHODS: In this longitudinal cohort study, 248 students with asthma, from 38 inner-city schools, underwent baseline phenotyping and follow-up. Clinical outcomes were evaluated throughout the academic school year and linked to classroom-specific dust and air endotoxin levels as well as home dust endotoxin levels. The primary outcome was maximum asthma symptom-days per 2-week period. RESULTS: Classrooms had higher settled dust endotoxin levels compared with homes (14.3 endotoxin unit/mg vs 11.3 endotoxin unit/mg; P = .02). Airborne endotoxin levels exceeding recommended occupational exposure limits for adults were recorded in 22.0% of classrooms. Classroom air endotoxin levels were independently associated with increased maximum symptom-days in children with nonatopic asthma, but not in those with atopic asthma (interaction P = .03). Adjusting for home exposures, classroom endotoxin exposure was independently associated with a dose-dependent increase in asthma symptom-days for children with nonatopic asthma (adjusted incidence rate ratio, 1.16 [95% CI, 1.03-1.31]; P = .02). In these subjects, maximum symptom-days increased by 1.3 days for each 14-day period when comparing students in classrooms with the lowest endotoxin levels compared with average measured levels. CONCLUSIONS: Inner-city children with asthma are exposed to high levels of airborne endotoxin at school, resulting in increased asthma symptoms in children with nonatopic asthma. Mitigation of school-related exposures may represent a strategy to decrease asthma morbidity in this population. TRIAL REGISTRY: ClinicalTrials.gov; No.: NCT01756391; URL: www.clinicaltrials.gov.
Authors: D L Rosenstreich; P Eggleston; M Kattan; D Baker; R G Slavin; P Gergen; H Mitchell; K McNiff-Mortimer; H Lynn; D Ownby; F Malveaux Journal: N Engl J Med Date: 1997-05-08 Impact factor: 91.245
Authors: Brian Boehlecke; Milan Hazucha; Neil E Alexis; Robert Jacobs; Parker Reist; Philip A Bromberg; David B Peden Journal: J Allergy Clin Immunol Date: 2003-12 Impact factor: 10.793
Authors: O Michel; J Kips; J Duchateau; F Vertongen; L Robert; H Collet; R Pauwels; R Sergysels Journal: Am J Respir Crit Care Med Date: 1996-12 Impact factor: 21.405
Authors: Wayne J Morgan; Ellen F Crain; Rebecca S Gruchalla; George T O'Connor; Meyer Kattan; Richard Evans; James Stout; George Malindzak; Ernestine Smartt; Marshall Plaut; Michelle Walter; Benjamin Vaughn; Herman Mitchell Journal: N Engl J Med Date: 2004-09-09 Impact factor: 91.245
Authors: Wanda Phipatanakul; Petros Koutrakis; Brent A Coull; Choong-Min Kang; Jack M Wolfson; Stephen T Ferguson; Carter R Petty; Mihail Samnaliev; Amparito Cunningham; William J Sheehan; Jonathan M Gaffin; Sachin N Baxi; Peggy S Lai; Perdita Permaul; Liming Liang; Peter S Thorne; Gary Adamkiewicz; Kasey J Brennan; Andrea A Baccarelli; Diane R Gold Journal: Contemp Clin Trials Date: 2017-06-12 Impact factor: 2.226
Authors: Marissa Hauptman; Jonathan M Gaffin; Carter R Petty; William J Sheehan; Peggy S Lai; Brent Coull; Diane R Gold; Wanda Phipatanakul Journal: J Allergy Clin Immunol Date: 2019-09-23 Impact factor: 10.793
Authors: Peggy S Lai; Amir H Massoud; Mingcan Xia; Carter R Petty; Amparito Cunningham; Talal A Chatila; Wanda Phipatanakul Journal: J Allergy Clin Immunol Date: 2017-09-21 Impact factor: 10.793
Authors: Peggy S Lai; Raivo Kolde; Eric A Franzosa; Jonathan M Gaffin; Sachin N Baxi; William J Sheehan; Diane R Gold; Dirk Gevers; Ramnik J Xavier; Wanda Phipatanakul Journal: J Allergy Clin Immunol Date: 2018-03-05 Impact factor: 10.793